Suchergebnisse - "Gesierich, Wolfgang"

PubPharm (81)

31

Screening for Bronchoscopic Lung Volume Reduction : Reasons for Not Receiving Interventional Treatment

enthalten in: Lung | 2020

von May, N. | Niehaus-Gebele, C. | Reichenberger, F. | +2

32

enthalten in: Pneumo news | 2020

von Gesierich, W.

33

enthalten in: Pneumo news | 2020

von Gesierich, W.

34

enthalten in: Pneumo news | 2020

von Gesierich, W.

35

enthalten in: Pneumo news | 2020

von Gesierich, W.

36

enthalten in: Pneumo news | 2020

von Gesierich, W.

37

enthalten in: Pneumo news | 2020

von Gesierich, W.

38

Two-year outcomes for the double-blind, randomized, sham-controlled study of targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2

enthalten in: The International journal of chronic obstructive pulmonary disease | 5 November 2020

von Valipour, A. | Shah, P. | Herth, F. | +20

39

Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD : AIRFLOW-2

enthalten in: International journal of chronic obstructive pulmonary disease | 2020

von Valipour, A. | Shah, P. | Herth, F. | +21

40

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial

enthalten in: American journal of respiratory and critical care medicine | 2019

von Slebos, D. | Shah, P. | Herth, F. | +95

CommentIn: Am J Respir Crit Care Med. 2019 Dec 15;200(12):1455-1456. - PMID 31469579